Individualized Empiric Vancomycin Dosing in Neonates Using a Model-Based Approach

Abstract

A model-based dosing approach that individualizes empiric vancomycin dosing was predicted to improve achievement of target exposure levels in neonates. Prospective clinical evaluation is warranted.